CLOSED STUDIES / Ovarian cancer

MM-121 / GEICO 1202


A Phase II Randomized Open Label Study of MM-121 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Platinum Resistant/ Refractory Advanced Ovarian Cancers.

GEICO Investigators:

Dr. Antonio González (PI). MD Anderson International
Dr. Andrés Redondo (PI). Hospital La Paz
Dr. Josep María Del Campo Fornis (PI). Hospital Vall D´Hebrón
Dr. María Jesús Rubio Pérez (PI). Hospital Reina Sofía de Córdoba
Dr. Andrés Poveda Velasco (PI). Instituto Valenciano de Oncologia IVO

Patients Recruited:


Inclusion Closing Date:

February of 2013

Current State